Post Profile

Medical News Today: Metformin may prevent multidrug-resistant breast cancer

Type 2 diabetes drug metformin has been found to inhibit and reverse the development of multidrug resistance in vitro in breast cancer cells.
read more


Related Posts

Blocking Ran protein reverses resistance of lung and breast cancers

Health : EurekAlert: Health

(University of Bradford) Researchers at the University of Bradford (UK) have discovered a way to prevent chemotherapy resistance in lung cancer by blocking a protein found in cancer cells.Suppressing this protein, called Ran-GTP, al...

Diabetes Drug Metformin Holds Promise for Cancer Treatment and Prevention, Penn Studies Find

Health : Newswise Medical News

Use of Metformin - commonly used as the front-line treatment for type 2 diabetes - improves survival for some breast cancer patients, and shows promise as a treatment for patients diagnosed with endometrial hyperplasia, according to...

Sunshine Biopharma's Adva-27a Is 16-times More Effective At Killing Multidrug Resistant Breast Cancer Cells

Health : Medical News Today

Sunshine Biopharma Inc. (OTCBB: SBFM), a development stage pharmaceutical company focused on the research, development and commercialization of drugs for the treatment of various forms of cancer, today announced that it has complete...

Overcoming Multidrug-Resistant Cancer with Smart Nanoparticles

Health : Newswise Medical News

Multidrug resistance (MDR) is the mechanism by which many cancers develop resistance to chemotherapy. Researchers have developed nanoparticles that simultaneously deliver chemotherapy drugs to tumors and inhibit the MDR proteins tha...

Diabetes drug metformin inhibits multidrug-resistant breast cancer

Diseases & Conditions / Cancer : EurekAlert: Cancer

(PLOS) The drug metformin, typically prescribed to treat type 2 diabetes, keeps breast cancer cells from developing multiple drug resistance (MDR) and can reverse MDR after it¹s appeared, according to a study published Dec. 6, 2017 ...


Copyright © 2016 Regator, LLC